Global /China /Healthcare /Medical Devices /2160

MicroPort CardioFlow Medtech Corp.

2160

• SHEK: 2160 • Delayed

2.40HKD -2.8%

0.3062 USD

As of 13 June 2026, MicroPort CardioFlow Medtech Corp. has a market cap of $401.3M USD, ranking #16654 globally and #5203 in China. It ranks #1506 in the Healthcare sector, and #318 in the Medical Devices industry.

Global Rank

16654

Country Rank

5203

Sector Rank

1506

Industry Rank

318

Key Stats

Market Cap

$401.3MUSD

3.15B HKD

Enterprise Value

$443.92MUSD

3.48B HKD

Revenue (TTM)

$56.65MUSD

444.0M HKD

EBITDA (TTM)

-$17.02MUSD

-133.42M HKD

Net Income (TTM)

-$18.69MUSD

-146.48M HKD

EBITDA Margin

-30%

Profit Margin

-33%

PS Ratio

7.1

PB Ratio

1.6

Company Profile

Country (HQ)

China

Sector

Healthcare

Industry

Medical Devices

CEO

Ruinian Zhang open_in_new

Employees

417

Founded

2009

Website

cardioflowmedtech.com open_in_new

warningChart data may be delayed

1d	1w	1m	3m	6m	YTD	1y	3y	5y
-2.8%	-5.8%	-24%	-43%	-60%	-60%	-46%	-79%	-97%

News

Markets

Exchange	Ticker	Price	Quotes
Hong Kong Stock Exchange (SHEK / HKEX) MIC: XHKG PRIMARY	2160 ISIN: KYG6082P1211 Shares Out.: Shares Outstanding: 1.273B¹ Shares Float: 505.122M² TV: TradingView: HKEX: 2160 SA: Stock Analysis: HKG: 2160 YF: Yahoo Finance: 2160.HK GF: Google Finance: HKG: 2160 BA: Barron's: 2160 MS: Morningstar: XHKG: 02160	2.40 HKD	TV: TradingView: HKEX: 2160 SA: Stock Analysis: HKG: 2160 YF: Yahoo Finance: 2160.HK GF: Google Finance: HKG: 2160 BA: Barron's: 2160 MS: Morningstar: XHKG: 02160

¹Market cap is calculated using shares outstanding.

²Float shares are publicly tradable shares, excluding insider-held stock.

About MicroPort CardioFlow Medtech Corp.

MicroPort CardioFlow Medtech Corporation, a medical device company, engages in the research, development, and commercialization of transcatheter and surgical solutions for structural heart diseases in the People’s Republic of China and internationally. The company engages in research and development, manufacture, and sale of medical devices in the field of left atrial appendage, and treating valvular heart diseases, as well as properties management. It’s product portfolio includes transcatheter aortic valves, left atrial appendage closure, transcatheter mitral valves, transcatheter tricuspid valves, and surgical accessories, as well as procedural accessories; and VitaFlow, VitaFlow Liberty, VitaFlow Liberty Flex, Alwide Plus, AccuSniperTM, AnchorMan LAAC System, AnchorMan LAAA System, and various TAVI, TMV, TTV, and LAA products. In addition, the company provides technical consultation and technical services for medical devices clinical trial. MicroPort CardioFlow Medtech Corporation was founded in 2009 and is headquartered in Shanghai, China.

Similar Companies

Industry: Medical Devices (China)

Name	Market Cap (USD) diff.	PE	Country
Shenzhen Mindray Bio-Medical Electronics Co., Ltd. SHE: 300760	$30.06B 203.66B CNY 7K%	26.0	China
Shanghai United Imaging Healthcare Co., Ltd. SSE: 688271	$13.61B 92.23B CNY 3K%	48.5	China
Shenzhen New Industries Biomedical Engineering Co., Ltd. SHE: 300832	$5.61B 38.02B CNY 1K%	23.4	China
Intco Medical Technology Co., Ltd. SHE: 300677	$5.52B 37.43B CNY 1K%	52.7	China
APT Medical Inc. SSE: 688617	$5.04B 34.14B CNY 1K%	39.6	China
Andon Health Co., Ltd. SHE: 002432	$4.55B 30.86B CNY 1K%	13.7	China

Industry: Medical Devices (Global)

Name	Market Cap (USD) diff.	PE	Country
Thermo Fisher Scientific Inc. NYSE: TMO	$173.27B 43K%	25.8	United States
Intuitive Surgical, Inc. NASDAQ: ISRG	$160.73B 40K%	56.7	United States
Abbott Laboratories NYSE: ABT	$159.07B 40K%	25.6	United States
Danaher Corp. NYSE: DHR	$126.55B 31K%	34.7	United States
Stryker Corp. NYSE: SYK	$120.69B 30K%	38.3	United States
Medtronic plc NYSE: MDT	$101.9B 25K%	22.2	Ireland

chevron_leftBack